While their SWNTs combined with PTT failed to fully inhibit the growth of a simulated metastasis, the team found that the addition of anti-CTLA-4 enhanced their treatment leading to significant inhibition of the secondary tumor and increased survival in their murine model.90 This evidence concerns the gene CTLA4 and neoplasm.